National Cancer Institute (NCI)

Elucidation of the Application of Blood Test Biomarkers to Predict Immune-Related Adverse Events in Atezolizumab-Treated NSCLC Patients Using Machine Learning Methods (2022) Zhou JG, Wong AHH, Wang H, Tan F, Chen X, Jin SH, He SS, et al. Journal article Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2022) Dorling L, Carvalho S, Allen J, Parsons MT, Fortuno C, Gonzalez-Neira A, Heijl SM, et al. Journal article Genome-wide and transcriptome-wide association studies of mammographic density phenotypes reveal novel loci (2022) Chen H, Fan S, Stone J, Thompson DJ, Douglas J, Li S, Scott C, et al. Journal article Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes (2022) Mavaddat N, Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Keeman R, Bolla MK, et al. Journal article Rare germline copy number variants (CNVs) and breast cancer risk (2022) Dennis J, Tyrer JP, Walker LC, Michailidou K, Dorling L, Bolla MK, Wang Q, et al. Journal article Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature (2022) Chlopek M, Lasota J, Thompson LDR, Szczepaniak M, Kuzniacka A, Hincza K, Kubicka K, et al. Journal article Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force (2022) Cuvelier GD, Schoettler M, Buxbaum NP, Pinal-Fernandez I, Schmalzing M, Distler J, Penack O, et al. Journal article, Review article Identification of an endogenous retroviral signature to predict PD-1 blockade response in advanced clear cell renal cell carcinoma: Integrated analysis of three clinical trials (2021) Zhou JG, Wang H, Ma H, Gaipl U Conference contribution Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis (2021) Escala-Garcia M, Canisius S, Keeman R, Beesley J, Anton-Culver H, Arndt V, Augustinsson A, et al. Journal article An engineered IL-2 partial agonist promotes CD8+ T cell stemness (2021) Mo F, Yu Z, Li P, Oh J, Spolski R, Zhao L, Glassman CR, et al. Journal article